Description
Presenter: Sharmin Ghaznavi, M.D., Ph.D.
Overview.
In light of the growing interest in psychedelic assisted psychotherapy, using a lecture and discussion format, this presentation will provide a comprehensive overview of psychedelic assisted psychotherapy, beginning with the history of psychedelic research, from the 1950’s to the present day. The course will review the basic neuropharmacology of psychedelic compounds and their properties. From there, the course will provide an in-depth overview of the research on psychedelic compounds. The course will cover recent clinical trials of the use of psychedelic-assisted psychotherapy for a range of psychiatric conditions, including, but not limited to treatment resistant depression and post-traumatic stress disorder. Risks and benefits of psychedelic assisted psychotherapy will also be discussed. After this presentation, attendees should have a solid understanding about the history and science of psychedelic assisted psychotherapy research, including the evidence-base to date, to facilitate discussions with their patients considering pursuing it through clinical trials, in treatment venues outside the United States where these compounds are legal, and eventually when some of these compounds are approved for use here in the United States.
Objectives.
- Summarize the history of research on psychedelic assisted psychotherapy from the 1950’s to the more recent renewed interest.
- Discuss the current evidence base for psychedelic assisted psychotherapy for a number
About the Presenter.
Sharmin Ghaznavi, MD, PhD, is the Associate Director and the Scientific Director of Cognitive Neuroscience at the Center for the Neuroscience of Psychedelics (CNP) at Massachusetts General Hospital. She is leading the Center’s first studies on the effects of psilocybin on rumination and other cognitive processes in treatment resistant depression. Dr. Ghaznavi received her undergraduate degrees in biology, brain and cognitive sciences, and philosophy from the Massachusetts Institute of Technology. She obtained her medical degree, masters degree in philosophy, and PhD in neuroscience from Yale University and completed a residency in adult psychiatry at the Mass General/McLean Psychiatry Residency Program. Dr. Ghaznavi’s research interests are the neural correlates of cognitive, affective and relational processing in psychiatric illness. Dr. Ghaznavi has been the recipient of the Dupont-Warren and Livingston psychiatric research fellowships from Harvard Medical School and a 2012 NARSAD Young Investigator Award from the Brain and Behavior Research Foundation.
Cost
FREE for MEMBERS
$10.00 for Non-Members
SCP Member?
Apply Coupon to get this webinar for free.